Comparative sensitivity of urinary cyfra 21-1, urinary bladder cancer antigen, tissue polypeptide antigen and NMP22 to detect bladder cancer

Journal of Urology

Volumn 162, Issue 6, 1999, Pages 1951-1956

  Sánchez Carbayo, Marta ^a   Herrero, Enrique ^a   Megías, Julián ^a   Mira, Antonio ^a   Soria, Federico ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

Biological; Bladder neoplasms; Tissue polypeptide antigen; Tumor markers; Urine

Indexed keywords

CYTOKERATIN; NUCLEAR PROTEIN; TISSUE POLYPEPTIDE ANTIGEN; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 0345440047     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)68076-7     Document Type: Article

References (25)

1. Newling, D. W.: Preventing recurrence and progression in superficial bladder cancer. Curr. Opin. Urol., 6: 272, 1996.
2. Foresman, W. H. and Messing, E. M.: Bladder cancer: natural history, tumor markers and early detection strategies. Sem. Surg. Oncol., 13: 299, 1997.
3. Morris, S. B., Gordon, E. M., Shearer, R. J. and Woodhouse, C. R.: Superficial bladder cancer: for how long should a tumor-free patient have check cystoscopies? Brit. J. Urol., 75: 193, 1995.
4. Badalament, R. A., Harmansen, D. K., Kimmel, M., Gay, H., Herr, H. W., Fair, W. R., Whitmore, W. F., Jr. and Melamed, M. R.: The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma. Cancer, 60: 1423, 1987.
5. Cordon-Cardo, C., Wartinger, D. D., Melamed, M. R., Fair, W. and Fradet, Y.: Immunopathologic analysis of human urinary bladder cancer. Characterization of two new antigens associated with low grade superficial bladder tumors. Amer. J. Path., 140: 375, 1992.
6. Sarosdy, M. F., De Vere White, R. W., Soloway, M. S., Sheinfeld, J., Hudson, M. A., Schellhammer, P. F., Jarowenko, M. V., Adams, G. and Blumenstein, B. A.: Results of a multicenter trial using BTA test to monitor for and diagnose recurrent bladder cancer. J. Urol., 154: 379, 1995.
7. D'Hallewin, M. A. and Baert, L.: Initial evaluation of the bladder tumor antigen test in superficial bladder cancer. J. Urol., 155: 475, 1996.
8. Soloway, M. S., Briggman, J. V., Carpinito, G. A., Chodak, G. W., Church, P. A., Lamm, D. L., Lange, P., Messing, E., Pasciak, R. M., Reservitz, G. B., Rukstalis, D. B., Sarosdy, M. F., Stadler, W. M., Thiel, R. P. and Hayden, C. L.: Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J. Urol., 156: 363, 1996.
9. Carpinito, G. A., Stadler, W. M., Briggman, J. V., Chodak, G. W., Church, P. A., Lamm, D. L., Lange, P. H., Messing, E. M., Pasciak, R. M., Reservitz, G. B., Ross, R. N., Rukstalis, D. B., Sarosdy, M. F., Solouay, M. S., Thiel, R. P., Vogelzang, N. and Hayden, C. L.: Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tract. J. Urol., 156: 1280, 1996.
10. Miyanaga, N., Akaza, H., Ishikawa, S., Ohtani, M., Noguchi, R., Kawai, K., Koiso, K., Kobayashi, M., Koyama, A. and Takahashi, T.: Clinical evaluation of nuclear matrix protein 22 (NMP22) in urine as a novel marker for urothelial cancer. Eur. Urol., 31: 163, 1997.
11. Stampfer, D. S., Carpinito, G. A., Rodriguez-Villanueva, J., Willsey, L. W., Dinney, C. P., Grossman, H. B., Fritsche, H. A. and McDougal, W. S.: Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder. J. Urol., 159: 394, 1998.
12. Landman, J., Chang, Y., Kavaler, E., Droller, M. J. and Liu, B. C.: Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer. Urology, 52: 398, 1998.
13. Schmetter, B. S., Habicht, K. K., Lamm, D. L., Morales, A., Bander, N. H., Grossman, H. B., Hanna, M. G., Jr., Silberman, S. R. and Butman, B. T.: A multicenter trial evaluation of the fibrin/fribrinogen degradation products test for detection and monitoring of bladder cancer. J. Urol., 158: 801, 1997.
14. Johnston, B., Morales, A., Emerson, L., and Lundie, M.: Rapid detection of bladder cancer: a comparative study of point of care tests. J. Urol., 158: 2098, 1997.
15. Sánchez-Carbayo, M., Herrero, E., Megías, J., Mira, A., Espasa, A., Chinchilla, V. and Soria, F.: Initial evaluation of urinary bladder cancer antigen as a tumor marker for bladder cancer. J. Urol., 161: 1110, 1999.
16. Grossman, H. B.: New methods for detection of bladder cancer. Sem. Urol. Oncol., 16: 17, 1998.
17. Moll, R., Franke, W. W., Schiller, D. L., Geiger, B. and Krepler, R.: The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell, 31: 11, 1982.
18. Fuchs, E.: Keratins as biochemical markers of epithelial differentiation. Trends Genet., 4: 277, 1988.
19. Bodenmüller, H.: The biochemistry of CYFRA 21-1 and other cytokeratin-tests. Scand. J. Clin. Lab. Invest., 221: 60, 1995.
20. Pariente, J. L., Bordenave, L., Michel, P., Latapie, M. J., Ducassou, D. and Le Guillou, M.: Initial evaluation of CYFRA 21-1 diagnostic performances as a urinary marker in bladder transitional cell carcinoma. J. Urol., 158: 338, 1997.
21. Björklund, B. and Björklund, V.: Antigenicity of pooled human malignant and normal tissues by citoimmunological technique: presence of an insoluble, heatlabile tumor antigen. Int. Arch. Allergy, 10: 153, 1957.
22. Berezney, R. and Coffey, D. S.: Identification of a nuclear protein matrix. Biochem. Biophys. Res. Comm., 60: 1410, 1974.
23. Getzenberg, R. H., Konety, B. R., Oeler, T. A., Quigley, M. M., Hakam, A., Becich, M. J. and Bahnson, R. R.: Bladder cancer-associated nuclear matrix proteins. Cancer Res., 56: 1690, 1996.
24. Keesee, S., Briggman, J. V., Thill, G. and Wu, Y. J.: Utilization of nuclear matrix proteins for cancer diagnosis. Crit. Rev. Eukaryot Gene Exp., 6: 189, 1996.
25. Wiener, H. G., Vooijs, G. P. and van't Hof-Grootenboer, B.: Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer. Acta. Cytol., 37: 163, 1993.